| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.021 | 0.9 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.04 | 0.9 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |